News
MyChesCo on MSN7h
FDA Requests Additional Data for Savara’s MOLBREEVI ApplicationLANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced receiving a Refuse-to-File (RTF) letter from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback